Netcapital Inc. (NCPL): Nasdaq/NYSE listing notice — Netcapital receives Nasdaq bid price deficiency notice; cure deadline Aug 3, 2026

Netcapital Inc.

Nasdaq notified Netcapital on Feb 4, 2026 that bid price closed below $1.00 for 30 consecutive trading days.
Company has 180 calendar days, until August 3, 2026, to regain compliance.
To cure, closing bid must be at least $1.00 for a minimum of 10 consecutive business days.
If not cured, may receive a second 180-day period if it meets market value and initial listing standards.
Netcapital may consider a reverse stock split to address the deficiency.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Netcapital Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

February 4, 2026, Netcapital Inc. (the “Company”) was notified (the “Notification Letter”) by The Nasdaq Stock Market, LLC (“Nasdaq”) that it is not in compliance with the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days. Based

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Netcapital Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-005589

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.